Skip to main content
Top
Published in: Neurosurgical Review 4/2006

Open Access 01-10-2006 | Original Article

Clinical and radiological features related to the growth potential of meningioma

Authors: Hidetoshi Kasuya, Osami Kubo, Masahiko Tanaka, Kosaku Amano, Koichi Kato, Tomokatsu Hori

Published in: Neurosurgical Review | Issue 4/2006

Login to get access

Abstract

Clinical and radiological features that help predict the growth potential of meningioma would be beneficial. The purpose of this study is to clarify the characteristics related to proliferating potential using the MIB-1 staining index. We analyzed the relationship of MIB-1 staining indices to characteristics of 342 consecutive patients with meningioma surgically removed between 1995 and 2004 by logistic regression analysis. One hundred and forty-nine of the patients with meningioma were ≥60 in age; 89 male; 48 recurrent; 203 symptomatic; 157 at the skull base; 124 over 20 cm3; 24 multiple; 136 with edema; 117 with calcification. The MIB-1 staining index in 56 of 296 grade I meningiomas in WHO classification was3.0; in 27 of 28 grade II; and in 17 of 18 grade III, respectively. Logistic regression analysis demonstrated that male (odds ratio [OR], 2.374, p=0.003), recurrence (OR, 7.574, p=0.0001), skull base (OR, 0.540, p=0.035), calcification (OR, 0.498, p=0.019) were independent risk factors for a high MIB-1 staining index (≥3.0); age, symptomatic, volume, multiple, edema were not. Male, recurrence, non-skull base, absence of calcification are independent risk factors for a high proliferative potential. These should be taken into consideration when managing meningiomas.
Literature
1.
go back to reference Aguiar PH, Tsanaclis AM, Tella OI, Plese JP (2003) Proliferation rate of intracranial meningiomas as defined by the monoclonal antibody MIB-1. Neurosurg Rev 26:221–228PubMed Aguiar PH, Tsanaclis AM, Tella OI, Plese JP (2003) Proliferation rate of intracranial meningiomas as defined by the monoclonal antibody MIB-1. Neurosurg Rev 26:221–228PubMed
2.
go back to reference Cattoretti G, Becker MHG, Key G, Duchrow M, Schluter C, Galle J, Gerdes J (1992) Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168:357–363PubMedCrossRef Cattoretti G, Becker MHG, Key G, Duchrow M, Schluter C, Galle J, Gerdes J (1992) Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168:357–363PubMedCrossRef
3.
go back to reference Ho DMT, Hsu CY, Ting LT, Chiang H (2002) Histopathology and MIB-1 labeling index predicted recurrence of meningiomas. Cancer 94:1538–1547PubMedCrossRef Ho DMT, Hsu CY, Ting LT, Chiang H (2002) Histopathology and MIB-1 labeling index predicted recurrence of meningiomas. Cancer 94:1538–1547PubMedCrossRef
4.
go back to reference Ide M, Jimbo M, Yamamoto M, Umebara Y, Hagiwara S, Kubo O (1996) MIB-1 staining index and peritumoral brain edema of meningiomas. Cancer 78:133–143PubMedCrossRef Ide M, Jimbo M, Yamamoto M, Umebara Y, Hagiwara S, Kubo O (1996) MIB-1 staining index and peritumoral brain edema of meningiomas. Cancer 78:133–143PubMedCrossRef
5.
go back to reference Jaaskelainen J, Haltia M, Laasonen E, Wahlstrom T, Valtonen S (1985) The growth rate of intracranial meningiomas and its relation to histology. Surg Neurol 24:165–172PubMedCrossRef Jaaskelainen J, Haltia M, Laasonen E, Wahlstrom T, Valtonen S (1985) The growth rate of intracranial meningiomas and its relation to histology. Surg Neurol 24:165–172PubMedCrossRef
6.
go back to reference Kakinuma K, Tanaka R, Onda K, Takahashi H (1998) Proliferative potential of recurrent intracranial meningiomas as evaluated by labelling indices of BUdR and Ki-67, and tumour doubling time. Acta Neurochir 140:26–32CrossRef Kakinuma K, Tanaka R, Onda K, Takahashi H (1998) Proliferative potential of recurrent intracranial meningiomas as evaluated by labelling indices of BUdR and Ki-67, and tumour doubling time. Acta Neurochir 140:26–32CrossRef
7.
go back to reference Kalala JP, Caemaert J, de Ridder L (2004) Primary resected meningiomas: relapses and proliferation markers. In vivo 18:411–416PubMed Kalala JP, Caemaert J, de Ridder L (2004) Primary resected meningiomas: relapses and proliferation markers. In vivo 18:411–416PubMed
8.
go back to reference Kayaselcuk F, Zorludemir S, Bal N, Erdogan B, Erman T (2004) The expression of surviving and Ki-67 in meningiomas: correlation with grade and clinical outcome. J Neuro-Oncol 67:209–214CrossRef Kayaselcuk F, Zorludemir S, Bal N, Erdogan B, Erman T (2004) The expression of surviving and Ki-67 in meningiomas: correlation with grade and clinical outcome. J Neuro-Oncol 67:209–214CrossRef
9.
go back to reference Kuratsu J, Kochi M, Ushio Y (2000) Incidence and clinical features of asymptomatic meningiomas. J Neurosurg 92:766–770PubMedCrossRef Kuratsu J, Kochi M, Ushio Y (2000) Incidence and clinical features of asymptomatic meningiomas. J Neurosurg 92:766–770PubMedCrossRef
10.
go back to reference Louis DN, Scheithauer BW, Budka H, von Deimling A, Kepes JJ (2000) Meningiomas. In: Kleihues P, Cavenee WK (eds) World Health Organization classification of tumours. Pathology and genetics of tumours of the nervous system. IARCPress, Lyon, France pp176–184 Louis DN, Scheithauer BW, Budka H, von Deimling A, Kepes JJ (2000) Meningiomas. In: Kleihues P, Cavenee WK (eds) World Health Organization classification of tumours. Pathology and genetics of tumours of the nervous system. IARCPress, Lyon, France pp176–184
11.
go back to reference Matsuno A, Fujimaki T, Sasaki T, Nagashima T, Ide T, Asai A, Matsuura R, Utsunomiya H, Kirino T (1996) Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomas. Acta Neuropathol 91:504–510PubMedCrossRef Matsuno A, Fujimaki T, Sasaki T, Nagashima T, Ide T, Asai A, Matsuura R, Utsunomiya H, Kirino T (1996) Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomas. Acta Neuropathol 91:504–510PubMedCrossRef
12.
go back to reference Nakaguchi H, Fujimaki T, Matsuno A, Matsuura R, Asai A, Suzuki I, Sasaki T, Kirino T (1999) Postoperative residual tumor growth of meningioma can be predicted by MIB-1 immunohistochemistry. Cancer 85:2249–2254PubMedCrossRef Nakaguchi H, Fujimaki T, Matsuno A, Matsuura R, Asai A, Suzuki I, Sasaki T, Kirino T (1999) Postoperative residual tumor growth of meningioma can be predicted by MIB-1 immunohistochemistry. Cancer 85:2249–2254PubMedCrossRef
13.
go back to reference Nakamura M, Roser F, Michel J, Jacobs C, Samii M (2003) The natural history of incidental meningiomas. Neurosurgry 53:62–71CrossRef Nakamura M, Roser F, Michel J, Jacobs C, Samii M (2003) The natural history of incidental meningiomas. Neurosurgry 53:62–71CrossRef
14.
go back to reference Nakasu S, Hirano A, Shimura T, Llena JF (1987) Incidental meningiomas at autopsy study. Surg Neurol 27:319–322PubMedCrossRef Nakasu S, Hirano A, Shimura T, Llena JF (1987) Incidental meningiomas at autopsy study. Surg Neurol 27:319–322PubMedCrossRef
15.
go back to reference Nakasu S, Nakajima M, Matsumura K, Nakasu Y, Handa J (1995) Meningioma: proliferating potential and clinicoradioloical features. Neurosurgery 37:1049–1055PubMedCrossRef Nakasu S, Nakajima M, Matsumura K, Nakasu Y, Handa J (1995) Meningioma: proliferating potential and clinicoradioloical features. Neurosurgery 37:1049–1055PubMedCrossRef
16.
go back to reference Niiro M, Yatsushiro K, Nakamura K, Kawahara Y, Kuratsu J (2000) Natural history of elderly patients with asymptomatic meningiomas. J Neurol Neurosurg Psychiatry 68:25–28PubMedCrossRef Niiro M, Yatsushiro K, Nakamura K, Kawahara Y, Kuratsu J (2000) Natural history of elderly patients with asymptomatic meningiomas. J Neurol Neurosurg Psychiatry 68:25–28PubMedCrossRef
17.
go back to reference Olivero WC, Lister JR, Elwood PW (1995) The natural history and growth rate of asymptomatic meningiomas: a review of 60 patients. J Neurosurg 83:222–224PubMedCrossRef Olivero WC, Lister JR, Elwood PW (1995) The natural history and growth rate of asymptomatic meningiomas: a review of 60 patients. J Neurosurg 83:222–224PubMedCrossRef
18.
go back to reference Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM (1998) The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas. Cancer 82:2262–2269PubMedCrossRef Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM (1998) The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas. Cancer 82:2262–2269PubMedCrossRef
19.
go back to reference Roser F, Samii M, Ostertag H, Bellinzona M (2004) Clinicopathological study. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases. Acta Neurochir 146:37–44CrossRef Roser F, Samii M, Ostertag H, Bellinzona M (2004) Clinicopathological study. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases. Acta Neurochir 146:37–44CrossRef
21.
go back to reference Yoneoka Y, Fujii Y, Tanaka R (2000) Growth of incidental meningiomas. Acta Neurochir 142:507–511CrossRef Yoneoka Y, Fujii Y, Tanaka R (2000) Growth of incidental meningiomas. Acta Neurochir 142:507–511CrossRef
Metadata
Title
Clinical and radiological features related to the growth potential of meningioma
Authors
Hidetoshi Kasuya
Osami Kubo
Masahiko Tanaka
Kosaku Amano
Koichi Kato
Tomokatsu Hori
Publication date
01-10-2006
Publisher
Springer-Verlag
Published in
Neurosurgical Review / Issue 4/2006
Print ISSN: 0344-5607
Electronic ISSN: 1437-2320
DOI
https://doi.org/10.1007/s10143-006-0039-3

Other articles of this Issue 4/2006

Neurosurgical Review 4/2006 Go to the issue